M. Jöbges

Intensive speech and language therapy in patients with chronic aphasia after stroke: a randomised, open-label, blinded-endpoint, controlled trial in a health-care setting

Caterina Breitenstein, Tanja Grewe, Agnes Flöel et al. · The Lancet · 2017 · 375 citations · Full text

Medicine, Neurology, Speech-language Pathology +17

Treatment of Tourette's Syndrome with Δ⁹-Tetrahydrocannabinol (THC): A Randomized Crossover Trial

Kirsten Müller‐Vahl, Udo Schneider, A. Koblenz et al. · Pharmacopsychiatry · 2002 · 255 citations

Medicine, Pharmacology, Pharmacotherapy +14

The influence of self-efficacy, pre-stroke depression and perceived social support on self-reported depressive symptoms during stroke rehabilitation

Adam B. Lewin, M. Jöbges, Katja Werheid · Neuropsychological Rehabilitation · 2013 · 67 citations

Social Sciences, Psychiatry, Psychology +17

Influence of Treatment of Tourette Syndrome with Δ9-Tetrahydrocannabinol (Δ9-THC) on Neuropsychological Performance

Kirsten Müller‐Vahl, A. Koblenz, M. Jöbges et al. · Pharmacopsychiatry · 2001 · 65 citations

Medicine, Pharmacology, Psychiatry +17

Predictivity of early depressive symptoms for post-stroke depression

A. Lewin-Richter, Matthias Volz, M. Jöbges et al. · The journal of nutrition health & aging · 2015 · 37 citations · Full text

Nursing, Neurology, Psychiatry +17